Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 608 | 897 | 1,347 | 1,905 | 2,548 |
| Receivables | 12 | 15 | 17 | 48 | 30 |
| TOTAL | $662 | $1,070 | $1,679 | $2,122 | $2,905 |
| Non-Current Assets | |||||
| Intangibles | 4,919 | 5,051 | 5,186 | 5,321 | 5,455 |
| TOTAL | $4,919 | $5,051 | $5,186 | $5,321 | $5,455 |
| Total Assets | $5,581 | $6,121 | $6,866 | $7,444 | $8,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 94 | 28 | 172 | 88 | 359 |
| TOTAL | $169 | $107 | $247 | $172 | $435 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $169 | $107 | $247 | $172 | $435 |
| Shareholders' Equity | |||||
| Common Shares | 13,579 | 13,579 | 13,579 | 13,579 | 13,579 |
| Retained earnings | -8,954 | -8,312 | -7,665 | -6,949 | -6,233 |
| TOTAL | $5,412 | $6,014 | $6,619 | $7,272 | $7,926 |
| Total Liabilities And Equity | $5,581 | $6,121 | $6,866 | $7,444 | $8,361 |